This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts
by Zacks Equity Research
ISRG's first-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results?
by Zacks Equity Research
GeneDx is expected to have continued the strong 2024 momentum across all metrics in the first quarter of 2025.
Here's Why Fresenius (FMS) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Fresenius Medical Care Stock Might be a Great Pick
by Zacks Equity Research
FMS has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Volatile Markets? Try These Relative Price Strength Stocks
by Nilanjan Choudhury
IHS, ATLC, REX and FMS are four stocks with explosive relative price strength.
Zacks.com featured highlights include Alibaba, Fresenius Medical, Helix Energy Solutions and Heritage Insurance
by Zacks Equity Research
Alibaba, Fresenius Medical, Helix Energy Solutions and Heritage Insurance have been highlighted in this Screen of The Week article.
4 Top-Ranked High Earnings Yield Value Stocks to Buy Right Away
by Rimmi Singhi
Unlock your portfolio value with value stocks like Alibaba, Fresenius Medical, Helix Energy and Heritage Insurance. All these stocks boast high earnings yield.
Is Concentra Group Holdings Parent, Inc. (CON) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Concentra Group (CON) and Fresenius (FMS) have performed compared to their sector so far this year.
Here's Why Fresenius (FMS) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Delcath Systems (DCTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence
by Sridatri Sarkar
In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR.
Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
by Zacks Equity Research
FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns.
4 PEG-Based Value Stocks to Buy Amid Tariff War and Market Bloodbath
by Urmimala Biswas
Here are four PEG-driven value stocks that fit our screening criteria. These are QFIN, SUZ, FMS and JD.
4 Stocks Trading Near 52-Week High With More Upside Potential
by Vasundhara Sawalka
Stocks like TAP, FMS, TGI and THG are seeing price strength and have a high chance of carrying the momentum forward.
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues
by Ritujay Ghosh
Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.
Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report?
by Zacks Equity Research
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree
by Zacks Equity Research
HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week article.
The Zacks Analyst Blog Highlights Reddit, Ubiquiti and Fresenius Medical Care AG
by Zacks Equity Research
Reddit, Ubiquiti and Fresenius Medical Care AG are part of the Zacks top Analyst Blog.
5 Relative Price Strength Stocks to Navigate Today's Market
by Nilanjan Choudhury
IHS, ANIP, MD, FMS and TREE are five stocks with explosive relative price strength.
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The March Job Report Informs Traders: Global Week Ahead
by John Blank
Under Elon Musk's DOGE government efficiency drive, tens of thousands of workers from the 2.3 million-strong federal workforce have been fired or agreed to take a buyout.
Zacks.com featured highlights include JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology
by Zacks Equity Research
JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology are part of the Zacks Screen of the Week article.
Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.